PL3193923T3 - Adiuwanty - Google Patents

Adiuwanty

Info

Publication number
PL3193923T3
PL3193923T3 PL15751144T PL15751144T PL3193923T3 PL 3193923 T3 PL3193923 T3 PL 3193923T3 PL 15751144 T PL15751144 T PL 15751144T PL 15751144 T PL15751144 T PL 15751144T PL 3193923 T3 PL3193923 T3 PL 3193923T3
Authority
PL
Poland
Prior art keywords
adjuvants
Prior art date
Application number
PL15751144T
Other languages
English (en)
Inventor
Lucas A. Th. Hilgers
Peter Paul L. I. PLATENBURG
Johannes F. Van Den Bosch
Original Assignee
Litevax B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Litevax B.V. filed Critical Litevax B.V.
Publication of PL3193923T3 publication Critical patent/PL3193923T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/145Orthomyxoviridae, e.g. influenza virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/06Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical being a hydroxyalkyl group esterified by a fatty acid
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55572Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL15751144T 2014-07-24 2015-07-24 Adiuwanty PL3193923T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL2013257 2014-07-24
EP15751144.5A EP3193923B1 (en) 2014-07-24 2015-07-24 Adjuvants
PCT/NL2015/050544 WO2016013938A1 (en) 2014-07-24 2015-07-24 Adjuvants

Publications (1)

Publication Number Publication Date
PL3193923T3 true PL3193923T3 (pl) 2020-03-31

Family

ID=52014300

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15751144T PL3193923T3 (pl) 2014-07-24 2015-07-24 Adiuwanty

Country Status (17)

Country Link
US (1) US10342867B2 (pl)
EP (1) EP3193923B1 (pl)
JP (1) JP6765371B2 (pl)
KR (1) KR102458982B1 (pl)
CN (1) CN106573047B (pl)
AU (1) AU2015294769B2 (pl)
BR (1) BR112017001121B1 (pl)
DK (1) DK3193923T3 (pl)
ES (1) ES2759542T3 (pl)
HR (1) HRP20192113T1 (pl)
HU (1) HUE047467T2 (pl)
LT (1) LT3193923T (pl)
NZ (1) NZ728551A (pl)
PL (1) PL3193923T3 (pl)
PT (1) PT3193923T (pl)
SI (1) SI3193923T1 (pl)
WO (1) WO2016013938A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4605414A1 (en) 2022-10-19 2025-08-27 GlyProVac ApS Glycosylated yghj polypeptides from uropathogenic e. coli
WO2025219177A1 (en) 2024-04-18 2025-10-23 Glyprovac Aps Optimized plasmids for expression of yghj polypeptides
NL2037924B1 (en) 2024-06-11 2026-01-12 Litevax B V Vaccination

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5600330A (en) 1994-07-12 1997-02-04 Ascension Technology Corporation Device for measuring position and orientation using non-dipole magnet IC fields
BE1008978A5 (fr) * 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
WO2001024784A2 (en) 1999-10-04 2001-04-12 Fujisawa Pharmaceutical Co., Ltd. New use
EP1104767A1 (en) * 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Mono- and disaccharide derivatives containing both fatty acid ester and sulfate ester groups
MXPA99011191A (es) 1999-12-03 2005-04-04 Univ Mexico Nacional Autonoma Inmunogeno, anti-veneno y vacuna contra el venenode la arana viuda negra.
JP2002080371A (ja) * 2000-06-23 2002-03-19 Seikagaku Kogyo Co Ltd プラスミノーゲンアクチベーター活性促進剤
FR2840318B1 (fr) * 2002-05-29 2004-12-03 Quoc Kiet Pham Nouveaux sulfolipides antiretroviraux extraits de spirulines, leur procede d'obtention, les compositions les contenant et leur utilisation comme inhibiteurs de la transcriptase inverse des virus vih
BRPI0713330A2 (pt) 2006-06-30 2012-04-17 The Scripps Research Institute adjuvantes e métodos de uso
JP4674696B2 (ja) 2007-04-03 2011-04-20 日本特殊陶業株式会社 スパークプラグの製造方法
EP2397484A1 (en) 2010-06-11 2011-12-21 Immunovo B.V. Trisaccharide derivates, and their use as adjuvants

Also Published As

Publication number Publication date
WO2016013938A1 (en) 2016-01-28
HUE047467T2 (hu) 2020-04-28
ES2759542T3 (es) 2020-05-11
US20170209568A1 (en) 2017-07-27
US10342867B2 (en) 2019-07-09
EP3193923B1 (en) 2019-09-18
LT3193923T (lt) 2019-12-10
NZ728551A (en) 2023-02-24
EP3193923A1 (en) 2017-07-26
JP2017522391A (ja) 2017-08-10
KR102458982B1 (ko) 2022-10-26
BR112017001121A2 (pt) 2018-01-23
CN106573047B (zh) 2021-10-12
DK3193923T3 (da) 2019-12-09
BR112017001121B1 (pt) 2023-11-07
HRP20192113T1 (hr) 2020-02-21
AU2015294769B2 (en) 2020-07-16
CA2954043A1 (en) 2016-01-28
CN106573047A (zh) 2017-04-19
SI3193923T1 (sl) 2020-02-28
PT3193923T (pt) 2019-12-05
JP6765371B2 (ja) 2020-10-07
KR20170040196A (ko) 2017-04-12
AU2015294769A1 (en) 2017-01-19

Similar Documents

Publication Publication Date Title
GB201410971D0 (en) Vaccine
AU362944S (en) Lapboard
PL3185899T5 (pl) Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd
DK3002465T3 (en) Hydrauliksystem
LT3193923T (lt) Adjuvantai
DK3194944T3 (en) Tomografiapparat
IL267264A (en) Auxiliary substances
GB201618479D0 (en) Adjuvants
SI3188755T1 (sl) Cepivo
GB201621375D0 (en) Adjuvants
DK3234061T3 (en) Nano-inhibitorer
GB2522661B (en) Context configuration
GB201417214D0 (en) Vaccine
GB201406628D0 (en) Vaccine
AU5598P (en) Lanidaho Mandevilla sanderi
AU5597P (en) Lancalifornia Mandevilla sanderi
AU5596P (en) Lannevada Mandevilla sanderi
AU5591P (en) Lanmontana Mandevilla sanderi
AU5287P (en) FLOMANPIW Mandevilla sanderi
AU5288P (en) FLOMANTOG Mandevilla sanderi
TWM490524U (en) Sucker
AU2014264V (en) FlatGL Templetonia retusa
AU2014265V (en) FlatdampGL Westringia dampieri
AU358508S (en) Bedhead
AU2014163V (en) CS004 Callistemon salignus